CRISPR's Evolution: Human Applications Since the CRISPR Babies Controversy

Post-CRISPR Babies Landscape

• 💡 The 2018 He Jiankui case, involving genetically edited embryos, sparked a global debate about ethics and safety in gene editing.
• 🔬 Since this controversy, CRISPR technology has indeed been used on humans, but with a focus on more controlled and ethical applications.

Ethical Clinical Trials

• 🚀 The first in vivo CRISPR therapy trial began in 2020, where scientists edited genes directly inside a patient to treat a rare inherited eye disease.
• ✅ This trial was conducted with strict monitoring for safety and effectiveness and reported no serious adverse effects.
• 📈 As of early 2025, there are approximately 250 clinical trials involving gene editing therapies, with over 150 currently active.
• 🎯 These trials cover a wide range of conditions, including blood cancers, inherited eye diseases, autoimmune diseases, and neurological conditions.

Approved Therapies and Broad Applications

• 👏 By 2023-2024, CRISPR-based therapies received regulatory approval for treating sickle cell disease and beta-thalassemia.
• 🧬 These approved therapies utilize somatic gene editing, meaning changes are made to non-reproductive cells and are not passed to future generations, addressing many ethical concerns.

Commitment to Safety and Ethics

• 🌱 The scientific community has shifted its focus from editing embryos to treating existing health issues in adults.
• 🔑 This change reflects a strong commitment to safety and ethical standards in medical research and the field of genetic engineering.